Rocket Lab (NASDAQ: RKLB) delivered record revenue and backlog in the second quarter, yet its shares fell after earnings as investors focused on execution.
Revenue rose 62% to $234.1 million, while backlog jumped 137% to $2.36 billion. The company guided for third-quarter revenue of $250 million to $265 million, above Wall Street expectations.
Shares nevertheless fell as much as 7% in extended trading after management said the window for launching Neutron before year-end was narrowing.
Rocket Lab’s demand problem is one most companies would want
Demand remains one of the strongest parts of Rocket Lab’s story.
Chief executive Peter Beck said the company had already entered into more than $1 billion of new launch and space-systems contracts in the third quarter.
Rocket Lab also ended Q2 with more than 90 launches in backlog, including US Space Force work.
Neutron is attracting customers before its first flight. Rocket Lab announced on Monday that Kepler Communications had booked a dedicated Neutron mission for no earlier than 2028.
Citizens analyst Trevor Walsh had argued before earnings that supplier checks showed healthy demand across the launch industry.
TipRanks reported that Walsh viewed Neutron as approaching a “key inflection point” and said successful execution could “raise the floor valuation” of Rocket Lab by removing a major uncertainty.
Neutron is now the source of the biggest uncertainty
Rocket Lab still expects to deliver Neutron to its launch pad in the fourth quarter, but the maiden flight timetable has become less certain.
Beck said the “window for an end-of-year launch is narrowing.” CFO Adam Spice said the company would “hopefully” launch within the same period.
For investors, that distinction matters. Neutron is central to Rocket Lab’s attempt to move beyond the smaller Electron vehicle and compete for larger commercial, civil and national-security missions.
Walsh’s earlier thesis highlights the stakes. A successful first flight and consistent launch cadence could materially reduce execution risk. By the same logic, every delay keeps that risk alive.
Rocket Lab is prioritising reliability over hitting a calendar date, but the stock market is less forgiving when a company’s valuation already assumes years of rapid expansion.
Why is Rocket Lab stock falling?
Neutron timing was not the only reason for caution.
Rocket Lab remains unprofitable, posting a Q2 net loss of $49.3 million, or 8 cents a share. Free cash flow was negative $110.1 million, while its operating loss reached $57.5 million.
Third-quarter revenue guidance was strong, but management forecast GAAP gross margins of 29% to 31%, below the 37.6% analysts expected. Rocket Lab said a greater mix of lower-margin satellite platforms would weigh on profitability.
Analysts called the quarter solid and highlighted the stronger revenue outlook, but concluded that investors were likely “hoping for more”.
Rocket Lab is growing quickly and its backlog shows customers want what it is building, but investors still need is proof that those contracts can become reliable launches, stronger margins and eventually sustainable cash generation.
The post Rocket Lab has more customers than it can handle, so why is the stock falling? appeared first on Invezz
